Tarsus Pharmaceuticals Inc (TARS)

Other Income/Expenses (Net)

$4.48M

TTM · Period ending: · USD

TARS logo

TARS Other Income/Expenses (Net)

Latest reported$4.48M
TARS TTM Other Income/Expenses (Net) (-$360.00K → $4.48M)
High-resolution chart · PNG

TARS other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Tarsus Pharmaceuticals Inc Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
4,482,000
2,253,000
6,610,000
6,256,000
6,054,000
4,222,000
5,015,000
6,255,000
6,300,000
7,685,000
7,265,000
6,179,000
4,782,000
2,866,000
617,000
-1,194,000
-1,917,000
-2,306,000
-1,615,000
-1,256,000
-919,000
2,000
188,000
-150,000
-202,000
-207,000
-360,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.